potent toxic human monocyt vitro vivo novel approach immunosuppress therapi lymphoid cell suscept excess dado inhibitor adenosin deaminas ada human monocyt sensit lymphocyt ada-resist congen cldado monocyt vitro cldado develop dna strand break dna damag toxic cldado monocyt deoxycytidin inhibitor poli adp-ribos polymeras partial decreas rna synthesi gradual declin cellular nad earli biochem event monocyt dna damag low cldado concentr nM monocyt phagocytosi releas interleukin cldado concentr dose- time-depend loss monocyt viabil monocyt wk patient cutan cell lymphoma rheumatoid arthriti continu cldado infus mark sensit human monocyt function surviv cldado vitro monocyt deplet patient cldado chemotherapi cldado dado analogu novel therapeut strategi chronic inflammatori autoimmun diseas inappropri monocyt deploy function 